Nomogram for predicting survival in patients treated with liposomal irinotecan plus fluorouracil and leucovorin in metastatic pancreatic cancer

Přispěvatelé: [Chen LT ] National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan. [Macarulla T] Hospital Universitari Vall d’Hebron, Barcelona, Spain. Vall d'Hebron Institut d'Oncologia (VHIO), Barcelona, Spain. [Blanc JF] Groupe Hospitalier Haut-Lévêque, CHU Bordeaux, Pessac, France. [Mirakhur B] Ipsen Biopharmaceuticals, Inc., Basking Ridge, USA. [Jong FA] Global Medical Affiars, Servier, Zürich, Switzerland. [Belanger B] Ipsen Biopharmaceuticals, Inc., Cambridge, USA, Hospital Universitari Vall d'Hebron
Rok vydání: 2021
Předmět:
Zdroj: Scientia
Databáze: OpenAIRE